February 4, 2014
Following on the heels of the issuance of USPTO patent number 8,632,523, describing a revolutionary method and device to administer Negative Pressure Wound Therapy (NPWT), Applied Tissue Technologies has been awarded a Phase I SBIR grant to investigate negative pressure wound therapy treatment when the treatment area is the complex architecture of the face and head.
The six month initial term of the grant will commence immediately, followed by Phase II term where the potential for additional testing and validation will be evaluated.
For further information about Applied Tissue Technologies or its products please contact:
Applied Tissue Technologies
275 Grove Street
Newton, MA 02466